The effectiveness of sleep breathing impairment index in assessing obstructive sleep apnea severity.

Wenhao Cao,J. Luo,R. Huang,Yi Xiao,L. Dai
DOI: https://doi.org/10.5664/jcsm.10302
2022-09-19
Abstract:STUDY OBJECTIVES Using the apnea-hypopnea index (AHI) and the sleep breathing impairment index (SBII) to assess the severity of obstructive sleep apnea (OSA), study how effective SBII is in assesing the severity and cardiovascular disease (CVD) prognosis. METHODS This study comprised a total of 147 patients with diagnosed OSA. The AHI and SBII was calculated from the polysomnography. Patients were enrolled in the cluster analysis using 20 symptoms and the SBII. The prognostic indicator was determined as the moderate-to-high Framingham 10-year CVD risk. RESULTS Cluster analysis revealed three separate groups. Cluster 1 (n=45, 30.61%) has the lowest symptoms complaints yet the highest PSQI score. Cluster 2 (n=70, 47.62%) had a considerably increased symptoms complaints but the lowest ESS score, intermediate PSG indices, a higher low arousal threshold (LAT) possibility, and a lower SBII quantile. Cluster 3 (n=32, 21.77%) has the largest percentage of smokers, a predominant symptom of restless in sleep, severe PSG characteristics, a low LAT likelihood, a greater SBII quantile and a higher Framingham CVD risk. There are no differences in the severity indicated by AHI between groups. Higher SBII rather than AHI is associated with an increased 10-year CVD risk. CONCLUSIONS SBII provides higher sensitivity when evaluating OSA severity and better predictive capabilities for CVD outcomes. SBII may be a more effective substitute for AHI in the future.
Medicine
What problem does this paper attempt to address?